Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Proficient Auto Logistics, a leader in North American auto transport and logistics, priced a $75 million private offering of convertible senior notes due 2033 at an initial conversion price premium of 27.5% over recent stock price. Net proceeds will refinance existing debt and pay premiums for capped call transactions designed to mitigate dilution.…
Silexion Therapeutics Corp., a clinical-stage biotech focused on RNAi therapies for KRAS-driven cancers, announced the pricing of a $2.5 million public offering consisting of 3,846,161 ordinary shares and series E warrants at $0.65 each. Proceeds will be used to advance its Phase 2/3 SIL204 clinical trial targeting locally advanced pancreatic cance…
Cheniere Energy has just cleared another milestone at Corpus Christi and is entering a multi-year capacity expansion cycle at a time when global LNG supply is under pressure. Fundamentals - contracted cash flows, solid free cash flow generation and visible capacity adds - make a long trade attractive over a 180-trading-day horizon with asymmetric u…
Anteris Technologies reported strong Q2 2026 results, highlighted by securing U.S. Medicare reimbursement eligibility for their pivotal PARADIGM Trial and initiating patient recruitment in the U.S. The trial, designed to evaluate Anteris's DurAVR® Transcatheter Heart Valve (THV) against commercial TAVR devices, is progressing globally with regulato…
Verizon Communications Inc. announced a $25,000 reward program for information leading to arrest and conviction of vandals damaging their fiber network, which has caused significant service interruptions, particularly in Los Angeles and Southern California. The company emphasized the safety risks posed by these criminal acts and is collaborating wi…
Southern Company ($SO) looks attractively positioned after a steady quarter, a supportive federal nuclear program, and a yield north of 3%. We upgrade to a buy and lay out an actionable trade with entry at $91.00, stop at $86.00, and a target of $100.84 over the next 180 trading days.
Seaport Therapeutics (SPTX) is a clinical-stage neuropsychiatry company trading at roughly $1.4B market cap with a tight float, high short interest and bullish technical momentum. The stock offers development-arbitrage upside if clinical/program milestones or partnership chatter re-rate the valuation; the trade is actionable with a mid-term horizon…
Ryman Hospitality Properties has priced a $700 million private placement of 6.25% senior notes due in 2035 to help finance the acquisition of the JW Marriott Orlando Grande Lakes Resort and The Ritz-Carlton Orlando, Grande Lakes. The acquisition's total price is approximately $1.38 billion and will be funded by these notes, a related common stock o…
JFB Construction Holdings and XTEND have received SEC approval for their proposed business combination via an effective Form S-4 filing. The merger is anticipated to close on September 1, 2026, at which point the combined entity will be renamed XTEND AI Robotics, Inc. and listed on the New York Stock Exchange under the ticker XTND. This marks a piv…
Marvell's sell-off has carved out a tactical buying opportunity. Strong AI-driven demand, healthy free cash flow and a clean balance sheet argue for a mid-term long. This trade plan gives a clear entry ($205.00), stop ($195.00) and target ($260.00) with a 45-trading-day horizon to let AI revenue momentum and technical mean reversion work in your fa…
Westport Fuel Systems Inc. reported its Q2 2026 financial results highlighting 125% revenue growth in its Cespira joint venture driven by strong demand for LNG HPDI trucks, along with progress in hydrogen technology development. Despite this, consolidated revenues declined due to the end of a service agreement, and net loss increased primarily due …
Eupraxia Pharmaceuticals announced its second quarter 2026 financial results, highlighting significant clinical progress in its EP-104GI trial for eosinophilic esophagitis (EoE), including improvements in fibrosis and inflammation. The company has strengthened its executive team and board to support late-stage development and commercialization effo…
Pfizer is an income-oriented pharma with a deep late-stage pipeline in obesity and oncology. The stock yields near 6.9%, trades around $26.60 and offers an asymmetric reward if late-stage assets like berobenatide and oncology candidates succeed. We lay out an actionable long trade with entry, stop and target and explain the catalysts, valuation con…
Siebert Financial Corp. reported robust second quarter 2026 results marked by a significant year-over-year increase in total revenue to $31.2 million, driven by growth in stock borrow/loan, investment banking, advisory fees, and commissions. The company narrowed its operating loss and expanded its platform capabilities through partnerships to offer…
Mount Logan Capital Inc. announced its Q2 2026 financial results, demonstrating a solid increase in segment income by 69% year-over-year to $7.5 million for the first half of the year. The Insurance Solutions segment showed notable strength with spread-related earnings rising significantly, helped by Ability Insurance Company's recent B+ AM Best ra…
LifeVantage Corporation announced that its Board of Directors granted inducement awards to its new President and CEO, Terrence Moorehead, under its 2026 New Employee Long-Term Incentive Plan, including restricted stock units and performance-based restricted stock units vesting over three years based on revenue and profitability targets.
Aardvark Therapeutics announced the termination of its Phase 3 HERO and OLE trials for ARD-101 in Prader-Willi Syndrome following a full clinical hold imposed by the FDA. The company is currently assessing unblinded trial data to decide on next steps. It reported a net loss of $14.4 million for Q2 2026 with a cash runway expected into late 2027.
Repsol’s ADR is an actionable long with a clear entry, stop and target. European refining capacity remains tight, supporting margins for companies with integrated refineries. At the same time, Repsol’s push into renewable fuels (notably the Ecoplanta waste-to-methanol contract) gives the stock optionality in the energy transition. Technicals show a…
A three-judge panel of the 5th U.S. Circuit Court of Appeals vacated a Department of Energy regulation that set efficiency standards for consumer gas and electric stoves and ovens, concluding the agency improperly used a direct final rule to avoid notice-and-comment procedures. The decision sided with seven Republican-led states that had challenged…
NOVAGOLD RESOURCES INC. and Donlin Gold Holdings LLC (owned by Paulson Advisers) have appointed Endeavour Financial and Macquarie Capital as financial advisors to support financing strategies for the Donlin Gold project in Alaska. The advisors will assist in evaluating funding alternatives, including project and infrastructure finance, to position …
Wendy's recent management change and a trimmed payout create the cash-flow and governance backdrop for a turnaround. At roughly $1.44B market cap and trading near $7.55, the stock is attractively valued on traditional metrics; this trade targets a mid-term rerating as execution and catalysts play out.
Apollomics Inc., a clinical-stage biopharmaceutical company focused on oncology therapies, announced a $10 million private placement. The financing includes cash investments and conversion of convertible notes from insiders and accredited investors, supporting ongoing clinical trials of its lead drug candidate, vebreltinib, for treating non-small c…
Stran & Company, Inc. (NASDAQ: SWAG) announced its financial results for Q2 and the first half of 2026, reporting revenue growth, improved gross profit, and doubled EBITDA compared to the prior year. The Company expanded its enterprise footprint with significant new contracts and continued to improve profitability in its loyalty solutions segment. …
FocalTherics announced preliminary unaudited Q2 2026 financial results, showing significant revenue and gross margin growth in its continuing HIFU segment. The company is exiting its ESWL and Distribution segments, marking a strategic shift to focus on robotic focal therapy technology. Cash and equivalents totaled $21.5 million as of June 30, 2026,…
Two Democratic U.S. senators have asked two Belgian companies to explain the circumstances surrounding an 18-carat gold ring set with 321 diamonds that was presented to President Donald Trump. The gift was delivered weeks before the U.S. moved to exempt European natural diamonds from newly proposed Section 301 tariffs. The senators say the timing a…
